Pandey, Smriti
Gao, Xin D. https://orcid.org/0000-0003-2917-2060
Krasnow, Nicholas A. https://orcid.org/0000-0002-4131-1855
McElroy, Amber
Tao, Y. Allen
Duby, Jordyn E.
Steinbeck, Benjamin J. https://orcid.org/0000-0002-6444-8643
McCreary, Julia
Pierce, Sarah E.
Tolar, Jakub https://orcid.org/0000-0002-0957-4380
Meissner, Torsten B. https://orcid.org/0000-0001-9729-5834
Chaikof, Elliot L.
Osborn, Mark J.
Liu, David R. https://orcid.org/0000-0002-9943-7557
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL160970)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U01 AI142756)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB031172)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG009490)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
Howard Hughes Medical Institute (Liu investigatorship)
Bill and Melinda Gates Foundation
Article History
Received: 6 December 2023
Accepted: 9 May 2024
First Online: 10 June 2024
Competing interests
: X.D.G., S.P. and D.R.L. have filed patent applications on this work. M.J.O. receives compensation as a consultant for Agathos Biologics. D.R.L. is a co-founder and consultant for Prime Medicine, Beam Therapeutics, Pairwise Plants, Chroma Medicine and Nvelop Therapeutics, and owns equity in these companies.